Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoko Masuda

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Inflammation and Regeneration|January 7, 2021
Possible NK cell-mediated immune responses against iPSC-derived cells in allogeneic transplantation settingsKyoko Masuda, Hiroshi Kawamoto
International Immunology|January 8, 2024
Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cell therapiesHiroshi Kawamoto, Kyoko Masuda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2016
Regeneration of tumor antigen-specific CTLs utilizing iPS technologyTakuya Maeda, Kyoko Masuda, Hiroshi Kawamoto
Advances in Experimental Medicine and Biology|March 12, 2024
Development of Immune Cell Therapy Using T Cells Generated from Pluripotent Stem CellsHiroshi Kawamoto, Kyoko Masuda, Seiji Nagano
International Immunology|October 18, 2021
Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technologyHiroshi Kawamoto, Kyoko Masuda, Seiji Nagano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 12, 2021
[The origin of blood cells and myeloid cells]Yosuke Nagahata, Kyoko Masuda, Hiroshi Kawamoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Mass-Production of Cytotoxic T Lymphocytes Regenerated from Pluripotent Stem Cells-To Target Solid Tumors]Soki Kashima, Kyoko Masuda, Hiroshi Kawamoto
International Journal of Hematology|February 2, 2018
Cloning and expansion of antigen-specific T cells using iPS cell technology: development of "off-the-shelf" T cells for the use in allogeneic transfusion settingsHiroshi Kawamoto, Kyoko Masuda, Seiji Nagano, et al.
Parasitology International|February 16, 2005
Mutagenicity evaluation of Schistosoma spp. extracts by the umu-test and V79/HGPRT gene mutation assayYoshio Osada, Takashi Kumagai, Kyoko Masuda, et al.
Immunological Reviews|October 26, 2010
A map for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid-based modelHiroshi Kawamoto, Tomokatsu Ikawa, Kyoko Masuda, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Inflammation and Regeneration|January 7, 2021
Possible NK cell-mediated immune responses against iPSC-derived cells in allogeneic transplantation settingsKyoko Masuda, Hiroshi Kawamoto
International Immunology|January 8, 2024
Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cell therapiesHiroshi Kawamoto, Kyoko Masuda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2016
Regeneration of tumor antigen-specific CTLs utilizing iPS technologyTakuya Maeda, Kyoko Masuda, Hiroshi Kawamoto
Advances in Experimental Medicine and Biology|March 12, 2024
Development of Immune Cell Therapy Using T Cells Generated from Pluripotent Stem CellsHiroshi Kawamoto, Kyoko Masuda, Seiji Nagano
International Immunology|October 18, 2021
Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technologyHiroshi Kawamoto, Kyoko Masuda, Seiji Nagano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 12, 2021
[The origin of blood cells and myeloid cells]Yosuke Nagahata, Kyoko Masuda, Hiroshi Kawamoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Mass-Production of Cytotoxic T Lymphocytes Regenerated from Pluripotent Stem Cells-To Target Solid Tumors]Soki Kashima, Kyoko Masuda, Hiroshi Kawamoto
International Journal of Hematology|February 2, 2018
Cloning and expansion of antigen-specific T cells using iPS cell technology: development of "off-the-shelf" T cells for the use in allogeneic transfusion settingsHiroshi Kawamoto, Kyoko Masuda, Seiji Nagano, et al.
Parasitology International|February 16, 2005
Mutagenicity evaluation of Schistosoma spp. extracts by the umu-test and V79/HGPRT gene mutation assayYoshio Osada, Takashi Kumagai, Kyoko Masuda, et al.
Immunological Reviews|October 26, 2010
A map for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid-based modelHiroshi Kawamoto, Tomokatsu Ikawa, Kyoko Masuda, et al.
Pageof 7